Home > BRISA > Search result
COVID-19

In this section you will find the HTA reports produced by RedETSA members in response to the COVID-19 pandemic. For additional resources, please visit PAHO’s website.


Limitation of Liability

The information, products, services, tools and/or opinions shared and expressed on the platform are the sole responsibility of the institutions that produce them, and do not necesarily represent the views of PAHO/WHO.

PAHO/WHO and its Specialized Center BIREME make no warranties nor guarantees the accuracy or truthfulness of the information, products, services and/or tools provided. Users must use these products, services and/or tools at their own risk. In no case will PAHO/WHO and its Specialized Center BIREME be liable for damages, even if they may have been warned and/or prevented.

Terms and conditions of use

Results: 2

Eficacia y seguridad de polihexanida 0. 1 % más undecilenamidopropil betaina 0. 1 % en pacientes con heridas crónicas en piel

Peru. EsSalud. Instituto de Evaluación de Tecnologías en Salud e Investigación.
INTRODUCCIÓN: El presente dictamen preliminar expone la evaluación de tecnología sanitaria (ETS) del antiséptico1 polihexanida 0.1 %, o polihexametilen biguanida, con betaína 0.1 % (PHMB), en solución o gel, en comparación con solución salina normal (SSN), para la limpieza de heridas crónicas en...
Pressure Ulcer/drug therapy, Varicose Ulcer/drug therapy, Diabetic Foot/drug therapy, Betaine/administration & dosage, Wound Healing, Wound Closure Techniques, Cost-Benefit Analysis, Efficacy
Fulltext

Undecilenamidopropil betaína (Prontosan solución/gel). Apósito de plata nanocristalina (Acticoat). Apósito de cadexómero de yodo (Iodosorb)

Hasdeu, Santiago; Carrasco, Gabriela; Montero, Guadalupe.
CONTEXTO: En el año 2013, la tercera ENFR mostró que tanto los resultados de prevalencia de realización de mediciones de la glucemia (76,8 %) como el autorreporte de diabetes o glucemia elevada (9,8 %) se incrementaron levemente respecto del 2009. La afectación macrovascular (aterosclerosis) determin...
Nanoparticles/administration & dosage, Betaine/analogs & derivatives, Methenamine/analogs & derivatives, Diabetic Foot/drug therapy, Technology Assessment, Biomedical, Cost Efficiency Analysis
Fulltext